The Hepatitis C Panel is based on molecular testing for direct detection of HCV in the bloodstream.
Unlike antibody tests, PCR assays identify viral RNA and confirm whether active infection is present.
Combining qualitative RT PCR with quantitative viral load measurement allows accurate diagnosis and clinical monitoring.

What does the panel include?

The panel includes:

• HCV RT PCR (Qualitative) – detection of Hepatitis C viral RNA in blood
• HCV PCR Quantitative – measurement of viral load (HCV RNA level)

Together, these tests confirm active infection and determine the level of viral replication.

Who is this panel suitable for?

• Positive HCV antibody screening result
• Suspected exposure to Hepatitis C
• Abnormal liver function tests
• Prior to initiating antiviral therapy
• Monitoring response to treatment

The panel is used to confirm active infection following initial serologic screening.

What is the advantage of a panel over a single test?

Antibody testing alone does not confirm active infection.
RT PCR detects viral RNA directly, while quantitative PCR measures viral load.

The combination allows clinicians to:

• Confirm active infection
• Assess viral replication level
• Monitor treatment response
• Verify viral clearance after therapy

How is the test performed?

• A venous blood sample is collected
• Fasting is not required
• No special preparation is necessary
• Patients should inform their physician about current antiviral therapy

How are the results interpreted?

A positive RT PCR result indicates active infection.
Quantitative results report viral load in international units (IU/mL).
A negative result indicates that viral RNA is not detected in the sample.

Interpretation is performed in the context of clinical findings and complementary investigations.

⚠️ Interpretation of results requires medical consultation.
Laboratory findings should not be interpreted without full clinical evaluation.

Possible complementary investigations

• Liver function tests (ALT, AST, bilirubin)
• HCV genotyping
• Hepatitis B and HIV testing
• Liver ultrasound
• FibroScan when indicated

Further medical evaluation

If active infection is confirmed, treatment planning is based on current clinical guidelines and individual patient factors.

During therapy, viral load monitoring is performed to assess response.

Consultation may be recommended with:

• Primary care physician
• Gastroenterologist
• Infectious disease specialist

Additional Professional Information

All tests are performed in a clinical laboratory operating in accordance with established professional standards and internal quality control procedures.
Results are issued in accordance with validated laboratory protocols.

Interpretation of findings is conducted within the framework of clinical evaluation by the treating physician.